INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Cancer Risk Reduction desk →

1,241 studies · page 48 of 52

2008 / Before-and-after intervention study

A 3-day forest bathing trip increased NK activity and anti-cancer protein expression in healthy female nurses, with effects lasting over 7 days.

Thirteen healthy female nurses participated in a 3-day/2-night forest bathing trip involving walking in forest fields. Blood and urine samples were collected before the trip, during the trip, and on days 7 and 30 post-trip. The trip significantly increased natural killer (NK) activity and numbers of NK cells, perforin, granulysin, and granzymes A/B-expressing cells, while significantly reducing the percentage of T cells and urinary adrenaline and noradrenaline levels. The elevated NK activity persisted for more than 7 days after the trip.

Li Q, Morimoto K, Kobayashi M, et al. J Biol Regul Homeost Agents, 2008. PMID 18394317

2008 / Randomized pilot trial

A plant- and fish-focused dietary intervention improved quality of life and lengthened PSA doubling time in men with recurrent prostate cancer.

Thirty-six men and their partners were randomized to 11 dietary and cooking classes integrating mindfulness or to a wait-list control group. The intervention group demonstrated significant reductions in saturated fat consumption, increased intake of vegetable proteins, decreased intake of animal proteins including dairy, and increased quality of life. While no significant difference was found in the rate of PSA increase or log PSA slope between groups, the mean PSA doubling time was substantially longer in the intervention group compared with controls at 3-month follow-up.

Carmody J, Olendzki B, Reed G, et al. Urology, 2008. PMID 18400281

2008 / Uncontrolled pre-post trial (participants served as own controls)

In patients with oral intraepithelial neoplasia, topical black raspberry gel was accompanied by histologic regression in a subset and reduced LOH indices.

Twenty-seven participants with oral intraepithelial neoplasia applied 0.5 g of a 10% freeze-dried black raspberry gel topically four times daily for 6 weeks, serving as their own internal controls. None of the 27 participants developed gel-associated toxicities. Results showed histologic regression in a subset of patients as well as a statistically significant reduction in loss of heterozygosity at tumor suppressor gene-associated loci.

Shumway BS, Kresty LA, Larsen PE, et al. Clin Cancer Res, 2008. PMID 18413833

2008 / Randomized controlled trial

Soy protein consumption led to lower prostate cancer detection compared with milk protein.

In a randomized trial, 58 men at risk of or with low-grade prostate cancer consumed 40 g daily of isoflavone-rich soy protein, alcohol-washed soy protein, or milk protein for 6 months. Serum PSA and prostate tissue biomarkers did not change with isoflavone-rich soy protein, whereas Bax expression decreased with alcohol-washed soy. A significantly lower rate of prostate cancer was detected in the soy groups compared to the milk group (P = 0.01).

Hamilton-Reeves JM, Rebello SA, Thomas W, et al. Nutr Cancer, 2008. PMID 18444130

2008 / Open-label nonrandomized phase II trial

Soy isoflavone supplementation was linked to slower PSA rise in recurrent prostate cancer.

In an open-label, nonrandomized phase II trial, 20 patients with prostate-specific antigen recurrence after previous local therapy consumed soy milk containing 47 mg of isoflavones three times daily for 12 months. An estimated annual PSA increase of 56% before entry slowed to 20% during the trial (p = 0.05). Post-entry slope was significantly reduced in 6 patients, increased in 2 patients, and remained statistically unchanged in 12 patients.

Pendleton JM, Tan WW, Anai S, et al. BMC Cancer, 2008. PMID 18471323

2008 / Pre-post trial with baseline hemisected lesion biopsy

Topical black raspberry gel application modulated gene expression and significantly reduced epithelial COX-2 protein in human oral premalignant lesions.

This study evaluated the effects of a 10% freeze-dried black raspberry gel applied topically (0.5 g four times daily for 6 weeks) to human oral intraepithelial neoplasia (IEN) lesions, using baseline hemisected biopsy samples as controls. Berry gel application uniformly suppressed genes linked to RNA processing, growth factor recycling, and apoptosis inhibition. Although most participants had posttreatment reductions in epithelial iNOS and COX-2 proteins, only the reductions in COX-2 reached statistical significance. In a subset of patients, berry gel application also reduced superficial connective tissue vascular densities and induced genes related to keratinocyte terminal differentiation.

Mallery SR, Zwick JC, Pei P, et al. Cancer Res, 2008. PMID 18559542

2008 / Pilot intervention study

An intensive nutrition and lifestyle intervention was associated with significant changes in prostate gene expression in men with low-risk prostate cancer.

A pilot study evaluated changes in prostate gene expression among men with low-risk prostate cancer undergoing active surveillance while participating in an intensive nutrition and lifestyle intervention. Significant improvements in weight, abdominal obesity, blood pressure, and lipid profiles were observed (all P < 0.05). Paired gene expression profiles from 30 participants revealed 48 up-regulated and 453 down-regulated transcripts after 3 months, with pathway analysis showing modulation of biological processes critical to tumorigenesis (P < 0.05).

Ornish D, Magbanua MJ, Weidner G, et al. Proc Natl Acad Sci U S A, 2008. PMID 18559852

2008 / Randomized controlled trial

Plant-based lifestyle program reduced conventional treatments in early-stage prostate cancer.

A randomized trial followed 93 patients with early-stage prostate cancer on active surveillance for two years. Participants were assigned to usual care or a one-year program of a low-fat, plant-based diet, exercise, stress management, and support groups. By two years, 5% (2 of 43) of lifestyle participants had undergone conventional prostate cancer therapy versus 27% (13 of 49) of controls (P < .05). Untreated groups did not differ in PSA change or velocity.

Frattaroli J, Weidner G, Dnistrian AM, et al. Urology, 2008. PMID 18602144

2008 / Multicenter randomized, controlled, single-blinded clinical trial

Iron reduction by phlebotomy decreased new visceral malignancy risk and mortality in patients with peripheral arterial disease.

A multicenter trial randomly assigned 1,277 peripheral arterial disease patients to iron reduction by phlebotomy (n = 636) or control (n = 641), followed for an average of 4.5 years. Risk of new visceral malignancy was lower in the iron reduction group compared to control (38 vs 60; HR = 0.65, 95% CI = 0.43 to 0.97; P = .036). Among patients who developed new cancers, those in the iron reduction group had lower cancer-specific mortality (HR = 0.39, 95% CI = 0.21 to 0.72; P = .003) and lower all-cause mortality (HR = 0.49, 95% CI = 0.29 to 0.83; P = .009).

Zacharski LR, Chow BK, Howes PS, et al. J Natl Cancer Inst, 2008. PMID 18612130

2008 / Phase II trial

Oral curcumin was well tolerated and showed biological activity in advanced pancreatic cancer

Twenty-five patients with advanced pancreatic cancer received 8 g of oral curcumin daily until progression. Circulating conjugates peaked at 22 to 41 ng/mL, reflecting poor bioavailability. Two of 21 evaluable participants showed biological activity, including one individual with stable disease exceeding 18 months and another with a temporary 73% tumor reduction. Curcumin down-regulated peripheral mononuclear cell expression of NF-kappaB, COX-2, and pSTAT3 without causing toxicities.

Dhillon N, Aggarwal BB, Newman RA, et al. Clin Cancer Res, 2008. PMID 18628464

2008 / Pilot clinical trial

Comprehensive lifestyle changes were associated with higher peripheral blood mononuclear cell telomerase activity.

A pilot study evaluated 30 men with low-risk prostate cancer asked to adopt comprehensive lifestyle modifications for 3 months. In 24 participants with adequate samples, natural log-transformed telomerase activity was 2.00 at baseline and 2.22 after 3 months (p = 0.031). Increased telomerase activity correlated with lower LDL cholesterol (r = -0.36, p = 0.041) and less psychological distress (r = -0.35, p = 0.047).

Ornish D, Lin J, Daubenmier J, et al. Lancet Oncol, 2008. PMID 18799354

2008 / Phase I/II clinical trial

A fungal beta-glucan preparation was tolerated by advanced cancer patients receiving chemotherapy.

In this phase I/II trial, 20 patients with advanced malignancies receiving chemotherapy received a beta-(1,3)/(1,6) D-glucan formulation. Investigators monitored participants for tolerability and effects on blood cell production. The authors concluded that the fungal supplement was well-tolerated and may have a beneficial effect on hematopoiesis during chemotherapy.

Weitberg AB J Exp Clin Cancer Res, 2008. PMID 18803849

2008 / Comparative clinical trial

Protein restriction, but not severe calorie restriction, decreased circulating IGF-1 in humans.

Researchers analyzed circulating markers from long-term human studies lasting 1 and 6 years. Severe calorie restriction with adequate nutrition did not change serum IGF-1 or the IGF-1 to IGFBP-3 ratio. In contrast, lowering protein intake from 1.67 to 0.95 g/kg/day for 3 weeks in six calorie-restricted volunteers reduced serum IGF-1 from 194 to 152 ng/mL.

Fontana L, Weiss EP, Villareal DT, et al. Aging Cell, 2008. PMID 18843793

2008 / Randomized controlled trial

Cooked neutropenic diets did not prevent major infections or death in leukemia patients.

Investigators randomly assigned 153 patients receiving remission induction therapy for acute myeloid leukemia in protected rooms to a cooked diet without raw produce (n=78) or a diet with fresh produce (n=75). Major infections developed in 29% of the cooked diet group and 35% of the raw diet group (P = .60). Time to major infection and survival were similar between groups, while fever of unknown origin occurred in 51% versus 36%.

Gardner A, Mattiuzzi G, Faderl S, et al. J Clin Oncol, 2008. PMID 18955453

2008 / Randomized controlled trial

Green tea extract lowered the recurrence of colorectal adenomas following polypectomy.

In a randomized trial, patients who had colorectal adenomas removed and confirmed clean colon at 1 year were assigned to 1.5 g green tea extract daily (n=71) or no supplementation (n=65) for 12 months. Among the 125 patients completing follow-up colonoscopy, the incidence of metachronous adenomas was 15% (9 of 60) in the green tea extract group versus 31% (20 of 65) in controls (relative risk, 0.49; 95% CI, 0.24-0.99; P < 0.05). Relapsed adenoma size was also significantly smaller in the supplemented group (P < 0.001), with no serious adverse events reported.

Shimizu M, Fukutomi Y, Ninomiya M, et al. Cancer Epidemiol Biomarkers Prev, 2008. PMID 18990744

2008 / Multisite randomized controlled trial

Flaxseed supplementation before surgery significantly lowered prostate cancer tumor proliferation rates, while low-fat diet alone did not.

Prostate cancer patients (n = 161) awaiting surgery were randomly assigned to a usual diet control, flaxseed supplementation (30 g/d), a low-fat diet (<20% energy), or a combined flaxseed and low-fat diet for an average of 30 days. Proliferation rates (Ki-67) were significantly lower (P < 0.002) in men in the flaxseed arms, with median Ki-67-positive ratios of 1.66 (flaxseed) and 1.50 (flaxseed + low-fat) compared to 3.23 (control) and 2.56 (low-fat). No significant differences between arms were observed for side effects, apoptosis, or most serologic endpoints, though low-fat diets significantly decreased serum cholesterol (P = 0.048).

Demark-Wahnefried W, Polascik TJ, George SL, et al. Cancer Epidemiol Biomarkers Prev, 2008. PMID 19064574

2008 / Randomized controlled primary prevention trial

A low-fat dietary pattern intervention did not significantly alter the risk of benign proliferative breast disease in postmenopausal women.

In the Women's Health Initiative Dietary Modification trial, 48,835 postmenopausal women were randomized to a dietary modification intervention (aiming for 20% energy from fat, >=5 servings/d fruits/vegetables, and >=6 servings/d grains) or a comparison group. Over an average follow-up of 7.7 years, 570 incident cases of benign proliferative breast disease occurred in the intervention group and 793 in the comparison group. The hazard ratio comparing the intervention group to the comparison group was 1.09 (95% CI, 0.98-1.23). The intervention resulted in smaller than targeted changes in practice, and risk varied by baseline total vitamin D intake.

Rohan TE, Negassa A, Caan B, et al. Cancer Prev Res (Phila), 2008. PMID 19138971

2008 / Phase II randomized controlled trial

Pre-prostatectomy lycopene supplementation increased plasma lycopene without toxicity, but hormonal and biomarker changes were not significant versus control.

Forty-five men with clinically localized prostate cancer were randomized to receive 15, 30, or 45 mg of lycopene or no supplement from biopsy to prostatectomy (approximately 30 days). Plasma lycopene increased in all treatment groups, with the greatest increase in the 45 mg arm compared to controls, without producing toxicity. Serum free testosterone decreased with 30 mg lycopene, and total estradiol increased significantly with 30 mg and 45 mg from baseline to post-treatment, with no significant increases in serum PSA or tissue Ki-67. However, these changes were not statistically significant compared to the control group for the study's sample size and duration.

Kumar NB, Besterman-Dahan K, Kang L, et al. Clin Med Urol, 2008. PMID 20354574

2007 / Prospective clinical trial

Oral beta glucan increased peripheral blood monocyte count and activation in advanced breast cancer.

Researchers evaluated the in vivo effects of daily oral 1-3, 1-6, D-beta glucan given for 15 days to 23 women with advanced breast cancer. Mean monocyte counts increased significantly from 326/mm3 to 496/mm3 (p=0.015). CD14-positive monocyte expression of CD95 rose from 48.17% to 69.23% (p=0.002) and CD45RA expression rose from 49.9% to 61.52% (p=0.001).

Demir G, Klein HO, Mandel-Molinas N, et al. Int Immunopharmacol, 2007. PMID 17161824

2007 / Interventional pilot study (before-and-after)

Consuming 500 g of broccoli daily for 6 days significantly induced CYP1A2 and CYP2A6 enzyme activities in Jordanian men and women.

Ten non-smoking Jordanian volunteers (5 men and 5 women) consumed a standard diet of 500 g of broccoli for 6 days, followed by caffeine testing on day 7 to measure CYP1A2 and CYP2A6 activities via urinary metabolite ratios. Following broccoli consumption, mean CYP1A2 activity significantly increased from 21.1+/-3.2 to 52.5+/-6.6 in men and from 27.6+/-1.6 to 36.6+/-8.4 in women (P<0.005). Mean CYP2A6 activity also significantly increased from 0.061+/-0.040 to 0.193+/-0.02 in men and from 0.144+/-0.039 to 0.214+/-0.064 in women (P<0.05).

Hakooz N, Hamdan I Curr Drug Metab, 2007. PMID 17266520

2007 / Phase I dose escalation pharmacokinetic study

Oral resveratrol was safe up to 5 g, but peak plasma levels were lower than concentrations typically required for in vitro cancer chemopreventive effects.

A phase I study evaluated single oral doses of resveratrol (0.5, 1, 2.5, or 5 g) in 10 healthy volunteers per dose level. Administration did not cause serious adverse events. Peak plasma levels of resveratrol at the 5 g dose were 539 +/- 384 ng/mL (2.4 micromol/L), occurring 1.5 hours post-dose, while peak levels of metabolites were 3- to 8-fold higher. The authors note that because in vitro cancer chemopreventive effects require at least 5 micromol/L, high-dose resveratrol might be insufficient to elicit systemic levels commensurate with efficacy, though conjugate metabolites warrant investigation.

Boocock DJ, Faust GE, Patel KR, et al. Cancer Epidemiol Biomarkers Prev, 2007. PMID 17548692

2007 / Randomized controlled trial

A comprehensive lifestyle intervention with a soy-supplemented vegan diet increased IGFBP-1 without selectively altering IGF-1 compared to usual care.

Researchers evaluated dietary intakes of total protein and soy isoflavones in relation to the IGF axis in prostate cancer patients participating in the Prostate Cancer Lifestyle Trial, which included a very low-fat vegan diet supplemented with 58 g/day of soy protein versus usual care. After one year, the intervention group reported significantly higher intakes of dietary protein and soy isoflavones than controls (P < 0.001). IGF-1 increased significantly in both groups, while IGFBP-1 rose in the experimental group only (P < 0.01). Increases in vegetable protein over one year were associated with increases in IGFBP-1 among intervention patients (P < 0.05).

Dewell A, Weidner G, Sumner MD, et al. Nutr Cancer, 2007. PMID 17571965

2007 / Randomized controlled trial

High-produce, high-fiber, low-fat diet did not lower breast cancer recurrence or death.

In a randomized trial of 3,088 women previously treated for early-stage breast cancer, an intensive telephone-counseling intervention promoted high vegetable, fruit, and fiber intake alongside low dietary fat. Over an average of 7.3 years of follow-up, invasive events occurred in 16.7% of intervention participants versus 16.9% of controls (adjusted HR, 0.96; 95% CI, 0.80-1.14). All-cause mortality was also similar between groups, reaching 10.1% versus 10.3% (adjusted HR, 0.91; 95% CI, 0.72-1.15).

Pierce JP, Natarajan L, Caan BJ, et al. JAMA, 2007. PMID 17635889